Sorry, you need to enable JavaScript to visit this website.

Study to Compare How Two Different Doses of Danuglipron Affect the Level of Rosuvastatin and Midazolam in the Blood of Adult Participants With Obesity

Study to Compare How Two Different Doses of Danuglipron Affect the Level of Rosuvastatin and Midazolam in the Blood of Adult Participants With Obesity. A Phase 1, Open‑Label, Fixed Sequence Study to Evaluate the Effect of Two Steady State Dose Levels of PF‑06882961 on the Pharmacokinetics of Single Oral Doses of Rosuvastatin and Midazolam in Otherwise Healthy Adult Participants With Obesity.

Category & Conditions: Diabetes and Metabolic Disorders
Medicine: danuglipron (PF-06882961)
ClinicalTrials.gov Identifier (NCT): NCT04621227
Protocol ID: C3421007
    Share
PrintDownload
Open Plain Language Summary Result: Click here